文献速递慢病管理预防保健、筛查与疫苗

CAPDCA个体化患者教育模型对糖尿病患者效果的整群随机对照研究

Effect of collection-assessment-plan-do-check-aggrandizement model of personalized patient education in patients with diabetes: a cluster randomized controlled study.
PubMed 文献 · Fam Pract · 2025-01-01

结果显示CAPDCA组最终HbA1c更低、HbA1c达标率更高(83.3% vs 25.0%,RR=3.33),空腹血糖、餐后2小时血糖、用药依从性(MMAS-8)及生活质量(SF-36)均优于对照组。

要点

  • CAPDCA组HbA1c达标率83.3%,对照组25.0%,风险比3.33(95%CI 2.29-4.84)。
  • CAPDCA组最终HbA1c更低且降幅更大(P<.01),空腹血糖与餐后2小时血糖降幅也显著更大。
  • CAPDCA组MMAS-8评分中位数7.0(IQR 6.75-7.5)及SF-36评分均显著高于对照组。

核心结论

  • CAPDCA个体化教育模型通过结构化、个体化的迭代教育改善糖尿病患者血糖控制、用药依从性和生活质量。
  • 该模型可扩展、可适配,为基层医疗机构实施个体化糖尿病教育提供了可行框架。

研究设计与样本

  • 多中心、两阶段整群随机对照试验,在北京市六家社区卫生中心开展。
  • 符合条件者随机分为CAPDCA模型组(n=90)和传统教育组(n=90),随访18个月共11次访视。
  • 178例完成试验(干预组90例,对照组88例),采用广义估计方程分析纵向趋势。

主要发现

  • 干预组最终HbA1c显著低于对照组(t=6.356,P<.01),HbA1c降幅也显著更大(t=-6.117,P<.01)。
  • HbA1c达标率干预组83.3%、对照组25.0%(风险比=3.33,95%CI 2.29-4.84,P<.01)。
  • 干预组空腹血糖(OR=0.663,95%CI 0.468-0.938)和餐后2小时血糖(OR=0.218,95%CI 0.138-0.345)降幅显著更大(P<.05)。
  • MMAS-8评分干预组改善至7.0(四分位距6.75-7.5),优于对照组(Z=5.912,P<.01)。
  • SF-36评分干预组更高(t=9.497,P<.01)。

关键数值与推荐

  • 主要结局为HbA1c降幅及达标率,次要结局包括空腹血糖、餐后2小时血糖、MMAS-8和SF-36。
  • HbA1c达标率干预组83.3% vs 对照组25.0%,风险比3.33(95%CI 2.29-4.84,P<.01)。
  • 空腹血糖组间比较OR=0.663(95%CI 0.468-0.938),餐后2小时血糖OR=0.218(95%CI 0.138-0.345)。
  • MMAS-8评分干预组中位数7.0(IQR 6.75-7.5),组间比较Z=5.912,P<.01。

临床怎么用

  • 在社区卫生中心可参考CAPDCA框架开展结构化、个体化且持续监测的糖尿病自我管理教育。
  • 该模型有望提升患者HbA1c达标率、用药依从性及生活质量,适合基层推广。

局限性

  • 原文摘要未报告局限性相关内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The global diabetes epidemic necessitates self-management strategies, and traditional patient education faces challenges in personalization, continuity, and monitoring. This study evaluates the efficacy of the collection-assessment-plan-do-check-aggrandizement (CAPDCA) model, which is a personalized patient education framework for improving glycemic control and self-management. METHODS: A multicenter, two-stage cluster randomized controlled trial was conducted across six community health centers in Beijing. Eligible participants were randomized into intervention (CAPDCA model, n = 90) or control (traditional education, n = 90) groups. Primary outcomes were HbA1c reduction and target achievement; secondary outcomes included fasting blood glucose (FBG) and 2-h postprandial blood glucose (2h-PPG), medication adherence (MMAS-8), and quality of life (SF-36). Follow-ups occurred over 18 months (11 visits). Generalized estimating equations (GEE) analyzed longitudinal trends. RESULTS: 178 participants completed the trial (90 in the intervention group and 88 in the control group). Compared to the control group, the intervention group demonstrated a significantly lower final HbA1c level (t = 6.356, P < .01) and a greater reduction in HbA1c (t = -6.117, P < .01). Target achievement rate of HbA1c is 83.3% in intervention and 25.0% in controls (risk ratio = 3.33, 95% CI: 2.29-4.84, P < .01). FBG (odds ratio (OR) = 0.663, 95% CI: 0.468-0.938) and 2h-PPG (OR = 0.218, 95% CI: 0.138-0.345) in intervention reductions were significantly greater (P < .05). MMAS-8 scores improved to 7.0 (inter-quartile range: 6.75-7.5) better than control group (Z = 5.912, P < .01). SF-36 scores is higher in the intervention group (t = 9.497, P < .01). CONCLUSIONS: The CAPDCA model enhances glycemic control, medication adherence, and quality of life in patients with diabetes through structured and personalized iterative education. Its scalability and adaptability address critical gaps in personalized diabetes education, offering a feasible framework for global implementation in primary healthcare institutions.

来源:Fam Pract,查看原文。版权归原作者所有。

引用

  1. Li J, Xing W, Liu YJ, et al. Effect of collection-assessment-plan-do-check-aggrandizement model of personalized patient education in patients with diabetes: a cluster randomized controlled study. Fam Pract. 2025. PMID: 41249891. doi:10.1093/fampra/cmaf086

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。